T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome
CA Klebanoff, SS Chandran, BM Baker… - Nature Reviews Drug …, 2023 - nature.com
The T cell receptor (TCR) complex is a naturally occurring antigen sensor that detects,
amplifies and coordinates cellular immune responses to epitopes derived from cell surface …
amplifies and coordinates cellular immune responses to epitopes derived from cell surface …
The cell stress and immunity cycle in cancer: toward next generation of cancer immunotherapy
The cellular stress and immunity cycle is a cornerstone of organismal homeostasis. Stress
activates intracellular and intercellular communications within a tissue or organ to initiate …
activates intracellular and intercellular communications within a tissue or organ to initiate …
[HTML][HTML] Glioblastoma vaccines: past, present, and opportunities
Glioblastoma (GBM) is one of the most lethal central nervous systems (CNS) tumours in
adults. As supplements to standard of care (SOC), various immunotherapies improve the …
adults. As supplements to standard of care (SOC), various immunotherapies improve the …
Boosting Theranostic Performance of AIEgens Using Nanocatalyzer for Robust Cancer Immunotherapy
Y Li, Z Du, Y Zhang, X Kang, J Song… - Advanced Functional …, 2024 - Wiley Online Library
High‐performance theranostic systems are of paramount importance for achieving precise
image‐guided cancer immunotherapy. Here, a novel nanoplatform is presented that …
image‐guided cancer immunotherapy. Here, a novel nanoplatform is presented that …
[HTML][HTML] Personalized cancer vaccines go viral: viral vectors in the era of personalized immunotherapy of cancer
The aim of personalized cancer vaccines is to elicit potent and tumor-specific immune
responses against neoantigens specific to each patient and to establish durable immunity …
responses against neoantigens specific to each patient and to establish durable immunity …
[HTML][HTML] Facts and hopes in immunotherapy strategies targeting antigens derived from KRAS mutations
GP Linette, AS Bear, BM Carreno - Clinical Cancer Research, 2024 - AACR
In this commentary, we advance the notion that mutant KRAS (mKRAS) is an ideal tumor
neoantigen that is amenable for targeting by the adaptive immune system. Recent progress …
neoantigen that is amenable for targeting by the adaptive immune system. Recent progress …
Elucidation of binding mechanism, affinity, and complex structure between mWT1 tumor‐associated antigen peptide and HLA‐A* 24: 02
GJ Bekker, N Numoto, M Kawasaki, T Hayashi… - Protein …, 2023 - Wiley Online Library
We have applied our advanced computational and experimental methodologies to
investigate the complex structure and binding mechanism of a modified Wilms' Tumor 1 …
investigate the complex structure and binding mechanism of a modified Wilms' Tumor 1 …
Phase and Defect Engineering of MoSe2 Nanosheets for Enhanced NIR-II Photothermal Immunotherapy
Inducing immunogenic cell death (ICD) during photothermal therapy (PTT) has the potential
to effectively trigger photothermal immunotherapy (PTI). However, ICD induced by PTT …
to effectively trigger photothermal immunotherapy (PTI). However, ICD induced by PTT …
Enzyme-Instructed Photoactivatable Supramolecular Antigens on Cancer Cell Membranes for Precision-Controlled T-Cell-Based Cancer Immunotherapy
Y Ding, S Zhang, W Li, X Chen, J Li, X Zhang… - Nano Letters, 2024 - ACS Publications
Cancer immunotherapies based on cytotoxic CD8+ T lymphocytes (CTLs) are highly
promising for cancer treatment. The specific interaction between T-cell receptors and …
promising for cancer treatment. The specific interaction between T-cell receptors and …
Ultrasound-Activatable In Situ Vaccine for Enhanced Antigen Self- and Cross-Presentation to Overcome Cancer Immunotherapy Resistance
G Chen, Y Wang, L Mo, X Xu, X Zhang, S Yang… - ACS …, 2024 - ACS Publications
Insufficient antigen self-presentation of tumor cells and ineffective antigen cross-
presentation by dendritic cells (DCs) contribute to diminished immune recognition and …
presentation by dendritic cells (DCs) contribute to diminished immune recognition and …